Loomis Sayles & Co. L P Raises Position in Integer Holdings Co. (NYSE:ITGR)

Loomis Sayles & Co. L P grew its stake in Integer Holdings Co. (NYSE:ITGR - Free Report) by 3.0% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 538,027 shares of the medical equipment provider's stock after buying an additional 15,446 shares during the period. Loomis Sayles & Co. L P owned approximately 1.60% of Integer worth $69,943,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in ITGR. Vanguard Group Inc. grew its holdings in shares of Integer by 0.6% during the 1st quarter. Vanguard Group Inc. now owns 3,826,088 shares of the medical equipment provider's stock valued at $446,428,000 after purchasing an additional 23,382 shares during the last quarter. Earnest Partners LLC grew its stake in shares of Integer by 3.2% during the second quarter. Earnest Partners LLC now owns 1,208,319 shares of the medical equipment provider's stock valued at $139,911,000 after buying an additional 37,340 shares during the last quarter. Congress Asset Management Co. increased its holdings in shares of Integer by 3.9% in the third quarter. Congress Asset Management Co. now owns 488,785 shares of the medical equipment provider's stock worth $63,542,000 after buying an additional 18,303 shares during the period. Charles Schwab Investment Management Inc. lifted its stake in shares of Integer by 1.2% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 404,029 shares of the medical equipment provider's stock valued at $52,524,000 after acquiring an additional 4,946 shares during the last quarter. Finally, Driehaus Capital Management LLC boosted its holdings in Integer by 62.5% during the 2nd quarter. Driehaus Capital Management LLC now owns 353,052 shares of the medical equipment provider's stock valued at $40,880,000 after acquiring an additional 135,750 shares during the period. Institutional investors own 99.29% of the company's stock.

Integer Stock Performance

Shares of NYSE ITGR traded up $2.17 during trading on Monday, hitting $140.28. The company had a trading volume of 281,977 shares, compared to its average volume of 309,189. The stock has a 50 day simple moving average of $130.22 and a 200 day simple moving average of $123.57. The firm has a market capitalization of $4.70 billion, a P/E ratio of 42.63, a price-to-earnings-growth ratio of 1.98 and a beta of 1.09. The company has a debt-to-equity ratio of 0.67, a quick ratio of 2.09 and a current ratio of 3.28. Integer Holdings Co. has a 12 month low of $84.75 and a 12 month high of $141.27.

Integer (NYSE:ITGR - Get Free Report) last announced its quarterly earnings data on Thursday, October 24th. The medical equipment provider reported $1.43 EPS for the quarter, beating the consensus estimate of $1.36 by $0.07. Integer had a return on equity of 11.63% and a net margin of 6.70%. The business had revenue of $431.42 million for the quarter, compared to the consensus estimate of $440.59 million. During the same period in the previous year, the business earned $1.27 earnings per share. The business's revenue was up 8.7% on a year-over-year basis. As a group, analysts anticipate that Integer Holdings Co. will post 5.34 earnings per share for the current year.

Analyst Ratings Changes

ITGR has been the subject of a number of analyst reports. Citigroup increased their target price on shares of Integer from $124.00 to $130.00 and gave the stock a "neutral" rating in a report on Tuesday, October 1st. Truist Financial decreased their target price on Integer from $150.00 to $147.00 and set a "buy" rating for the company in a research report on Friday, October 25th. KeyCorp lifted their price target on Integer from $139.00 to $144.00 and gave the company an "overweight" rating in a research report on Tuesday, October 15th. Benchmark increased their price objective on Integer from $130.00 to $140.00 and gave the stock a "buy" rating in a report on Monday, October 21st. Finally, Bank of America boosted their target price on shares of Integer from $135.00 to $145.00 and gave the company a "buy" rating in a report on Tuesday, October 1st. One equities research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to MarketBeat, Integer has an average rating of "Moderate Buy" and an average price target of $139.75.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.